July 2005
Diabetes Health;Jul2005, Vol. 14 Issue 7, p16
Interviews Gerald Bernstein, vice president of medical affairs at Generex Biotechnology, about the inhalable insulin Oral-lyn. Efforts of the company in seeking for the approval of Oral-lyn in the U.S.; Difference between insulin spray and inhaled insulin; Practical tips for people switching from injectable to spray insulin.


Related Articles

  • Sweet Relief. Verdezoto, María Elena // Latin Trade (English);Sep2006, Vol. 14 Issue 9, p14 

    The article offers information on Oral Lynn, a device used for injecting insulin to the body without using a syringe. Oral Lyn, a device for the mouth, is created by a strategic alliance between Generex Biotechnology and Pharmabrand. Oral Lyn enters the body as an aerosol under the tongue,...

  • Oral-lyn, the Oral Insulin Spray.  // Diabetes Health;Feb/Mar2010, Vol. 19 Issue 1, p24 

    The article evaluates the Generex Oral-lynâ„¢ insulin spray from Generex Biotechnology Corp.

  • Generex Biotechnology: vaccines a clear way ahead for RapidMist.  // PharmaWatch: Monthly Review;September 2004, Vol. 3 Issue 9, p50 

    Reports on chief scientific officer of Generex Biotechnology's Antigen Express immunomedicines subsidiary, Robert Humphreys' presentation of a research abstract at the Foundation Merieux Conference discussing the prospects for the company's RapidMist delivery system. Benefits of the technology...

  • REPORTER'S NOTEBOOK.  // Drug Store News;9/11/2006, Vol. 28 Issue 11, p40 

    The article offers news briefs related to pharmacy in the U.S. Adams Respiratory Therapeutics has contacted Adams clearing that it had submitted an abbreviated new drug application to the Food and Drug Administration for a single-ingredient extended-release formulation of guaifenesin. Generex...

  • GENEREX EXPANDS PLAN FOR FDA IND FOR ORAL-LYN.  // Biotech Business;May2010, Vol. 23 Issue 5, p3 

    The article reports the move of Generex Biotechnology Corp. to include licensed and qualified nurse practitioners in plans for its U.S. Food and Drug Administration (FDA) Expanded Access Treatment Investigational New Drug (IND) Program for its oral insulin Generex Oral-lyn. Under the program,...

  • A REMOTE-CONTROLLED MICRO INJECTOR. Rose, S.; Nelson, J. F. // Australian Journal of Experimental Biology & Medical Science;Aug1955, Vol. 33 Issue 4, p411 

    A simple, remote-controlled micro injector suitable for implantation into animals is described. The animal can thus receive a single injection of 0·02 to 0·2 ml. of drug by remote control and therefore without emotional disturbance.

  • Liquid medication and dosing devices. Kurtzweil, Paula // FDA Consumer;Oct94, Vol. 28 Issue 8, p6 

    Discusses the importance of administering medicine in proper doses. Extent of misuse; Various types of dosing instruments for liquid medicines; Benefits of syringes; Problems with syringe caps; Food and Drug Administration survey of various liquid medications. INSETS: How to use dosing...

  • Semi-Automated Testing of Nasal Sprays.  // Pharmaceutical Technology Europe;May2002, Vol. 14 Issue 5, p28 

    Focuses on a study which investigated the development of nasal spray formulation. Discussion on the engineering of drug delivery device; Guidelines imposed by the U.S. Food and Drug Administration on drug delivery device; Tests conducted on droplet sizing and laser diffraction.

  • Insulin admin in DM: patients prefer the pen.  // PharmacoEconomics & Outcomes News;8/23/2008, Issue 560, p8 

    The article discusses research on the use of insulin pens by patients with diabetes mellitus (DM). It references a study by E. M. Davis et al published in the July 15, 2008 issue of the "American Journal of Health-System Pharmacy." According to the study, many DM patients felt more satisfied and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics